Endo Questions Flashcards
. What is an excellent marker of the insulin-resistant condition in metabolic syndrome?
Hypertriglyceridemia
Hypertriglyceridemia is an excellent marker of the insulin-resistant condition.
Hyperuricemia reflects defects in insulin action on the renal tubular reabsorption of uric acid and may contribute to hypertension through its effect on the endothelium.
In the setting of insulin resistance, the vasodilatory effect of insulin is lost but the renal effect on sodium reabsorption is preserved. Insulin also increases the activity of the sympathetic nervous system, an effect that is preserved in the setting of insulin resistance.
42-year-old female came into the Endocrinology outpatient clinic for consultation. She also expressed the desire to be screened for obesity and its associated conditions. On physical examination, her BMI was 26 kg/m2, her waist circumference was 85cm, and her waist-hip ratio was 0.90. Which of the following is NOT an appropriate recommendation for this patient?
a.
Recommend screening for depression using Patient Health Questionnaire-9 every 6 months
b.
Recommend screening for dyslipidemia using fasting lipid profile
c.
Recommend screening for osteoarthritis using x-ray yearly
d.
Recommend screening for polycystic ovarian syndrome using Rotterdam criteria
Recommendations for work up for obesity
MODY type?
hepatocyte nuclear transcription factor 4-alpha
MODY 1: hepatocyte nuclear transcription factor 4-alpha
MODY 3: HNF 1-alpha
Progressive decline in glycemic control but may respond to sulfonylureas
MODY 5: HNF 1-beta
Progressive impairment of insulin secretion and hepatic insulin resistance, require insulin treatment with minimal response to SU
Other abnormalities: renal cysts, mild pancreatic exocrine insufficiency, abnormal LFTs
MODY 2: glucokinase gene mutations
Mild to moderate but stable hyperglycemia that does not respond to OHAs
Higher glucose levels needed to elicit insulin secretory responses (higher insulin setpoint)
MODY4: pancreatic and duodenal homeobox 1
Homozygous mutations: pancreatic agenesis
Heterozygous mutations: DM
MODY type?
HNF1 ALPHA
MODY 3: HNF 1-alpha
Progressive decline in glycemic control but may respond to sulfonylureas
MODY type?
HNF 1-beta
MODY 5: HNF 1-beta
Progressive impairment of insulin secretion and hepatic insulin resistance, require insulin treatment with minimal response to SU
MODY type?
glucokinase gene mutations
MODY 2: glucokinase gene mutations
Mild to moderate but stable hyperglycemia that does not respond to OHAs
Higher glucose levels needed to elicit insulin secretory responses (higher insulin setpoint)
MODY type _ ?
pancreatic and duodenal homeobox 1
MODY4: pancreatic and duodenal homeobox 1
Homozygous mutations: pancreatic agenesis
Heterozygous mutations: DM
insulin resistance syndrome affects young women and is characterized by severe hyperinsulinemia, obesity, and features of hyperandrogenism. This is usually due to an undefined defect in insulin-signaling pathway?
Type A insulin resistance syndrome affects young women and is characterized by severe hyperinsulinemia, obesity, and features of hyperandrogenism. This is usually due to an undefined defect in insulin-signaling pathway
Type Binsulin resistance syndrome affects middle-aged women and is characterized by severe hyperinsulinemia, features of hyperandrogenism, and autoimmune disorders. These patients have autoantibodies directed at the insulin receptor.
Polycystic ovary syndrome affects premenopausal women and is characterized by chronic anovulation and hyperandrogenism.
Lipodystrophies are characterized by selective loss of adipose tissue, leading to severe insulin resistance, and hypertriglyceridemia.
insulin resistance syndrome affects middle-aged women and is characterized by severe hyperinsulinemia, features of hyperandrogenism, and autoimmune disorders. These patients have autoantibodies directed at the insulin receptor.
Type B INsulin resistance
syndrome characterized by chronic anovulation and hyperandrogenism
PCOS
Polycystic ovary syndrome affects premenopausal women and is characterized by chronic anovulation and hyperandrogenism.
Lipodystrophies are characterized by selective loss of adipose tissue, leading to severe insulin resistance, and hypertriglyceridemia.
characterized by selective loss of adipose tissue, leading to severe insulin resistance, and hypertriglyceridemia?
Lipodystrophies are characterized by selective loss of adipose tissue, leading to severe insulin resistance, and hypertriglyceridemia.
What is the most common pattern of dyslipidemia in patients with diabetes mellitus?
Elevated triglycerides, low HDL
exercise-induced hypoglycemia mechanism?
a.
Defect in fatty acid oxidation including defects in the carnitine cycle, fatty acid beta-oxidation disorders, electron transfer disturbances, and ketogenesis disorders
b.
Defect in gluconeogenesis, particularly in fructose-1,6-bisphosphatase
c.
Increased activity of monocarboxylate transporter 1 in beta-cells leading to hyperinsulinemia
d.
Mutations in glucokinase, SUR1, or Kir6.2 potassium channel
C.Increased activity of monocarboxylate transporter 1 in beta-cells leading to hyperinsulinemia
Non-diabetic hypoglycemia also results from inborn errors of metabolism, where cases in adults can be classified into fasting hypoglycemia, postprandial hypoglycemia, and exercise-induced hypoglycemia.
A and B are enumerated mechanisms of fasting hypoglycemia.
D is a mechanism of inborn error of metabolism leading to postprandial hypoglycemia. Other errors include congenital disorders of glycosylation and inherited fructose intolerance.
1 unit of insulin for every __mg/dL
1 unit of insulin for every 30-60mg/dL
47-year-old male with Type 2 diabetes mellitus visited your clinic due to painful pins and needles sensation on his hands and feet. He has been experiencing this for 7 months now and has been taking paracetamol + tramadol which affords no relief. What is the best treatment option?
a.
Duloxetine
b.
Folic acid
c.
Tapentadol
d.
Vitamin B complex
TCAs
Diabetic neuropathy may respond to tricyclic antidepressants, venlafaxine, carbamazepine, tramadol, or topical capsaicin products. An 8% capsaicin patch requires application by a healthcare provider.
a centrally acting opioid, is also approved by the FDA, but has only modest efficacy and poses addiction risk, making it and other opioids less desirable and not a first-line therapy.
Tapentadol
Two oral agents approved by the U.S. Food and Drug Administration (FDA) initially used for pain associated with diabetic neuropathy.
duloxetine and pregabalin, or gabapentin
can be used to suppress insulin in sulfonylurea-induced hypoglycemia.
Octreotide
evaluation of gynecomastia
a condition that occurs when there are high levels of calcium and alkali in the body, leading to metabolic alkalosis and kidney damage
milk alkali syndrome